| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/11/1998 | WO1998039434A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/11/1998 | WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998039029A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 09/11/1998 | WO1998039024A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | WO1998039011A1 Photosensitizer conjugates for pathogen targeting |
| 09/11/1998 | WO1998039003A1 Use of (+)mefloquine for the treatment of malaria |
| 09/11/1998 | WO1998039000A1 Use of cholinesterase inhibitors to treat disorders of attention |
| 09/11/1998 | WO1998038987A1 Pharmaceutical formulations containing poorly soluble drug substances |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998038854A1 Pharmaceutical composition and methods for using it |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | CA2283379A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2283143A1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | CA2247799A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/10/1998 | DE19711503C1 Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen A pharmaceutical composition for the abolition of membrane-mediated resistance of cells |
| 09/09/1998 | EP0862629A1 Epithelial membrane protein-1 |
| 09/09/1998 | EP0862628A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/09/1998 | EP0862625A1 Methods for modulation of cholesterol transport |
| 09/09/1998 | EP0862462A1 A NOVEL COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND AN OPIOID |
| 09/09/1998 | EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 09/09/1998 | EP0862458A1 Urease for the treatment of helicobacter pylori infections |
| 09/09/1998 | EP0862457A1 Infusions of neuroprotectants and thrombolytic agents |
| 09/09/1998 | EP0862455A1 Interferon-polymer conjugates and process for preparing the same |
| 09/09/1998 | EP0862445A1 Methods and compositions for viral enhancement of cell killing |
| 09/09/1998 | EP0862444A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 09/09/1998 | EP0862434A1 Infusions of neuroprotectants and perfluorochemicals |
| 09/09/1998 | EP0862431A1 Pharmaceutical formulation |
| 09/09/1998 | CN1192732A CB2 receptor agonist compounds |
| 09/09/1998 | CN1192697A Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192696A Spironolactone and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 09/09/1998 | CN1192693A Therapeutic agent and autoimmune diseases |
| 09/09/1998 | CN1192689A Appetite regulating compositions |
| 09/09/1998 | CN1192688A Treatment of HIV and other viral infections using combinatory therapy |
| 09/09/1998 | CN1192684A Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 09/09/1998 | CN1192682A Compositions for use against parasitic protozoa |
| 09/09/1998 | CN1192678A Biological agent compositions |
| 09/09/1998 | CN1039672C Quick-drying gel-type disinfectant for hands and fingers |
| 09/08/1998 | US5804588 Quinoline carboxanides and their therapeutic use |
| 09/08/1998 | US5804571 Administering an s-omega(omega-aminoalkylamino)alkyl dihydrogen phosphorothioate |
| 09/08/1998 | US5804567 By administering a tea catechin, a theaflavin with an arabinofuranosylcytosine, 4-amino-10-methylfolic acid. |
| 09/08/1998 | US5804561 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/08/1998 | US5804549 Glycerol monolaurate, nisin in the absence of a chelator and a carrier |
| 09/03/1998 | WO1998038312A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | WO1998038310A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | WO1998038307A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | WO1998038193A1 Method for the preparation of (+)-calanolide a and analogues thereof |
| 09/03/1998 | WO1998037918A1 Staphylococcus 3-dehydroquinate synthase |
| 09/03/1998 | WO1998037917A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | WO1998037916A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | WO1998037905A1 Arrestable therapeutic viral agent |
| 09/03/1998 | WO1998037894A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 09/03/1998 | WO1998037880A1 Inhibitors of leaderless protein export |
| 09/03/1998 | WO1998037874A1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
| 09/03/1998 | WO1998026770A3 The topical use of kappa opioid agonists to treat ocular pain |
| 09/03/1998 | WO1998024397A3 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 09/03/1998 | CA2283107A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | CA2282736A1 Novel human transmembrane 4 superfamily protein |
| 09/03/1998 | CA2281925A1 Inhibitors of leaderless protein export |
| 09/03/1998 | CA2280690A1 Arrestable therapeutic viral agent |
| 09/03/1998 | CA2252942A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | CA2252790A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | CA2247072A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861666A2 Pharmaceutical composition for use in treatment of diabetes |
| 09/02/1998 | EP0861321A2 Phosphopantetheinyl transferases and uses thereof |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 09/02/1998 | EP0861088A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861081A1 Use of epinastine in the treatment of pain |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861070A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 09/02/1998 | EP0606217B1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 09/02/1998 | CN1192157A Method to prevent transplant rejection |
| 09/02/1998 | CN1192156A Treatment of T cell mediated autoimmune disorders |
| 09/02/1998 | CN1192149A Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 09/01/1998 | US5801234 Polynucleotide encoding saliva binding protein |
| 09/01/1998 | US5801159 Method and composition for inhibiting cellular irreversible changes due to stress |
| 09/01/1998 | US5801014 Growth differentiation factor-5 |
| 09/01/1998 | US5800838 Conbating sexually transmitted diseases; antiseptics |
| 09/01/1998 | US5800385 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 09/01/1998 | CA2086874E Methods for administration of taxol |
| 08/28/1998 | CA2230497A1 Novel lica |
| 08/27/1998 | WO1998037411A1 Assay for disease related conformation of a protein |
| 08/27/1998 | WO1998037198A1 Human sodium-dependent phosphate cotransporter |
| 08/27/1998 | WO1998037188A1 OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON |
| 08/27/1998 | WO1998037111A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein |
| 08/27/1998 | WO1998037085A1 Netrin receptors |
| 08/27/1998 | WO1998036776A2 Gel delivery vehicles for anticellular proliferative agents |